Diseases affecting the anterior segment of the eye are the primary causes of vision
impairment and blindness globally. Drug administration through the topical ocular route is …

Owing to the variety and complexity of ocular diseases and the natural ocular barriers, drug
therapy for ocular diseases has significant limitations, such as poor drug targeting to the site …

Global overpopulation, industrial expansion, and urbanization have generated massive
amounts of wastes. This is considered as a significant worldwide challenge that requires an …

Liquid metals (LMs) with high thermal/electrical conductivity, extraordinary fluidity, and
excellent biocompatibility have garnered considerable attention in the last decade …

Biocompatible, attuned, and congruent stimuli-responsive polymers of synthetic and plants
and animals-based origins are essential raw materials for constructing bio-matching …

Fungal keratitis (FK) is an infectious eye disease that poses a significant risk of blindness.
However, the effectiveness of conventional antifungal drugs is limited due to the intrinsic …

Diabetic retinopathy (DR) is a leading cause of irreversible vision loss in working-age
populations. Fat mass and obesity-associated protein (FTO) is an N6-methyladenosine …

Nanoparticles (NPs) based therapies for Alzheimer's disease (AD) attract interest due to
their ability to pass across or bypass the blood‐brain barrier. Chitosan (CS) NPs or …

Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over
76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040 …

Oxidative stress plays a central role in dry eye disease (DED), which can destroy the mucin
layer on the ocular surface. The currently available eye drops are palliative and short-lived …